van der Heijden, M. S. and Powles, T. B. and Galsky, M. D. and Catto, J. W. F. and Meeks, J. and Zukov, R. and Izumi, K. and Huang, K. H. and Bekir Hacioglu, M. and Hussain, S. A. and Necchi, A. and Dumez, H. and Schnabel, Marco J. and Bigot, P. and Estay, A. C. and Lui, A. G. A. and Cernadas, C. and Bigos, K. and Hois, S. and Nishiyama, H.
(2025)
Health-related quality of life (HRQoL) outcomes from the NIAGARA trial of perioperative durvalumab (D) plus neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC).
ANNALS OF ONCOLOGY, 36 (S2).
S1483.
ISSN 0923-7534, 1569-8041
Full text not available from this repository.
Actions (login required)
 |
View Item |